Musetta L, Helsper S, Roosen L, Maes D, Croitor Sava A, Vanherp L
J Fungi (Basel). 2024; 10(8).
PMID: 39194918
PMC: 11355240.
DOI: 10.3390/jof10080593.
Dewison K, Rowlinson B, Machin J, Crossley J, Thacker D, Wilkinson M
Proc Natl Acad Sci U S A. 2024; 121(34):e2315006121.
PMID: 39133842
PMC: 11348338.
DOI: 10.1073/pnas.2315006121.
Bjorklund A, Mattsson B
J Parkinsons Dis. 2024; 14(6):1077-1094.
PMID: 39031386
PMC: 11380285.
DOI: 10.3233/JPD-240207.
Sturchio A, Rocha E, Kauffman M, Marsili L, Mahajan A, Saraf A
Brain Sci. 2024; 14(2).
PMID: 38391726
PMC: 10887152.
DOI: 10.3390/brainsci14020151.
Gubinelli F, Sarauskyte L, Venuti C, Kulacz I, Cazzolla G, Negrini M
Curr Res Neurobiol. 2023; 4:100065.
PMID: 36632447
PMC: 9827042.
DOI: 10.1016/j.crneur.2022.100065.
Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease.
Kim J, Daadi E, Oh T, Daadi E, Daadi M
Genes (Basel). 2022; 13(11).
PMID: 36360174
PMC: 9689743.
DOI: 10.3390/genes13111937.
Selective neurodegeneration generated by intravenous α-synuclein pre-formed fibril administration is not associated with endogenous α-synuclein levels in the rat brain.
Kuan W, Alfaidi M, Horne C, Vallin B, Fox S, Fazal S
Brain Pathol. 2022; 33(3):e13128.
PMID: 36321260
PMC: 10154377.
DOI: 10.1111/bpa.13128.
A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System.
Bjorklund A, Nilsson F, Mattsson B, Hoban D, Parmar M
J Parkinsons Dis. 2022; 12(8):2307-2320.
PMID: 36189605
PMC: 9837691.
DOI: 10.3233/JPD-223452.
Dopaminergic Positron Emission Tomography Imaging in the Alpha-Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease.
Sossi V, Patterson J, McCormick S, Kemp C, Miller K, Stoll A
Mov Disord. 2022; 37(8):1739-1748.
PMID: 35524682
PMC: 9391270.
DOI: 10.1002/mds.29051.
α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives.
Alzghool O, van Dongen G, van de Giessen E, Schoonmade L, Beaino W
Mov Disord. 2022; 37(5):936-948.
PMID: 35289424
PMC: 9310945.
DOI: 10.1002/mds.28984.
Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits.
Negrini M, Tomasello G, Davidsson M, Fenyi A, Adant C, Hauser S
J Parkinsons Dis. 2022; 12(4):1133-1153.
PMID: 35213388
PMC: 9198765.
DOI: 10.3233/JPD-212555.
Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells.
Vasili E, Dominguez-Meijide A, Flores-Leon M, Al-Azzani M, Kanellidi A, Melki R
Mol Neurobiol. 2022; 59(2):1273-1284.
PMID: 34984585
PMC: 8857012.
DOI: 10.1007/s12035-021-02713-2.
α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson's Disease.
Stokholm K, Thomsen M, Phan J, Moller L, Bay-Richter C, Christiansen S
Biomedicines. 2021; 9(12).
PMID: 34944691
PMC: 8698691.
DOI: 10.3390/biomedicines9121876.
Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice.
Okuda S, Uemura N, Sawamura M, Taguchi T, Ikuno M, Uemura M
Neurotherapeutics. 2021; 19(1):289-304.
PMID: 34935120
PMC: 9130450.
DOI: 10.1007/s13311-021-01169-5.
Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons.
Ferrer-Lorente R, Lozano-Cruz T, Fernandez-Carasa I, Milowska K, de la Mata F, Bryszewska M
Biomacromolecules. 2021; 22(11):4582-4591.
PMID: 34613701
PMC: 8906628.
DOI: 10.1021/acs.biomac.1c00884.
Adeno-Associated Virus Expression of α-Synuclein as a Tool to Model Parkinson's Disease: Current Understanding and Knowledge Gaps.
Huntington T, Srinivasan R
Aging Dis. 2021; 12(4):1120-1137.
PMID: 34221553
PMC: 8219504.
DOI: 10.14336/AD.2021.0517.
T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils.
George S, Tyson T, Rey N, Sheridan R, Peelaerts W, Becker K
J Parkinsons Dis. 2021; 11(2):585-603.
PMID: 33579871
PMC: 8150548.
DOI: 10.3233/JPD-202351.
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A, Gelders G, Fenyi A, Bousset L, Brito F, Peelaerts W
Acta Neuropathol. 2020; 139(6):977-1000.
PMID: 32356200
PMC: 7244622.
DOI: 10.1007/s00401-020-02157-3.
Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson's disease.
Torre-Muruzabal T, Devoght J, Van den Haute C, Brone B, Van der Perren A, Baekelandt V
Acta Neuropathol Commun. 2019; 7(1):160.
PMID: 31640762
PMC: 6805517.
DOI: 10.1186/s40478-019-0814-3.
Excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging study.
Crabbe M, Dirkx N, Casteels C, Van Laere K
Sci Rep. 2019; 9(1):12916.
PMID: 31501497
PMC: 6733799.
DOI: 10.1038/s41598-019-49356-x.